SWM
ALT icon

SeaCrest Wealth Management’s Altimmune ALT Stock Holding History

SeaCrest Wealth Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-27,353
Closed -$115K – 630
2023
Q1 		$115K Buy
27,353
+3,818
+16% +$45.4K 0.02% 607
2022
Q4 		$387K Buy
+23,535
New +$264K 0.06% 387

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SeaCrest Wealth Management's ALT Position: Q2 2023 in Review

SeaCrest Wealth Management sold out of Altimmune (ALT) in Q2 2023, closing a stake of 27,353 shares — an estimated $115K sold.

SeaCrest Wealth Management first reported a position in ALT in Q4 2022 and held it in 2 quarters. The position peaked at $387K in Q4 2022. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

  • SeaCrest Wealth Management reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
  • SeaCrest Wealth Management sold 27,353 Altimmune shares in Q2 2023, an estimated $115K.
  • SeaCrest Wealth Management first reported a position in Altimmune in Q4 2022 and held it in 2 quarters.
  • SeaCrest Wealth Management's Altimmune position peaked at $387K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on SeaCrest Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.